ArticleJournal of Korean medical science2026
Hepatic Cysts in Korea: Prevalence, Incidence, and Risk Factors Based on a 5.8-Year Follow-up Health Screening Cohort.
Article in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundHepatic cysts are fluid-filled liver lesions that are mostly asymptomatic, but fewer than 15% of patients present clinically significant symptoms. Reported prevalence ranges from 2.5% to 71%, yet prior studies have been limited by small populations and incomplete assessment of risk factors. This study aimed to determine the prevalence, incidence, and risk factors using data from a large health screening cohort in Korea.
methodsWe performed a retrospective cohort analysis of 78,676 participants in the Health and Prevention Enhancement cohort who underwent abdominal ultrasound at the Seoul National University Hospital Healthcare System Gangnam Center from 2003 and 2014. Hepatic cysts were identified using a validated rule-based text-mining algorithm applied to ultrasound reports. Prevalence was estimated from baseline data. Incidence was assessed in 41,179 participants initially negative for hepatic cysts. Risk factors were determined through Cox proportional hazards modeling.
resultsThe prevalence of hepatic cysts at baseline was 8.54% (95% confidence interval [95% CI], 8.34-8.73). The incidence was 23.4 per 1,000 person-years at risk (95% CI, 22.8-24.0). Cox regression identified hepatitis B virus surface antigen (HBs-Ag) positivity (hazard ratio [HR], 1.20; 95% CI, 1.00-1.45) and renal cyst presence (HR, 1.46; 95% CI, 1.31-1.64) as independent risk factors, whereas diabetes mellitus (HR, 0.64; 95% CI, 0.54-0.77) and high physical activity (HR, 0.89; 95% CI, 0.81-0.97) appeared protective.
conclusionThis study provides the prevalence of 8.54%, incidence, and risk factors of hepatic cysts. Renal cyst presence and HBs-Ag positivity are significant risk factors, whereas high physical activity and diabetic status are protective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.